The post Coinbase now lets users borrow up to $1 million against staked Ether appeared on BitcoinEthereumNews.com. The new borrowing service allows eligible customersThe post Coinbase now lets users borrow up to $1 million against staked Ether appeared on BitcoinEthereumNews.com. The new borrowing service allows eligible customers

Coinbase now lets users borrow up to $1 million against staked Ether

The new borrowing service allows eligible customers to unlock up to $1 million in liquidity without unstaking their tokens by pledging their staked ether as collateral.

Coinbase has rolled out a feature on its staking platform, where traders can borrow USDC against the exchange’s representation of staked ether, cbETH. The product is available to users in the United States, excluding New York, with limited access in the United Kingdom, per details published on the company’s website.

Coinbase debuts cbETH collateralized lending for staking services 

According to the Nasdaq-listed exchange’s advertisement of the product, borrowers can request up to $1 million in USDC, with loan limits determined by the amount of eligible crypto posted as collateral and subject to loan-to-value requirements. 

Funds will be credited to the user’s Coinbase account immediately upon approval, while the pledged collateral is transferred onchain to a third-party protocol. The loans are powered by Morpho, a decentralized lending protocol that facilitates overcollateralized borrowing through smart contracts. 

Coinbase also disclosed that borrowers must maintain a loan-to-value ratio below 86% to avoid automatic liquidation and penalties. That threshold could come under pressure during extremely volatile market conditions for Ether, which is undoubtedly higher than for fiat currencies.

The crypto exchange would effectively extend the utility of its staked ether beyond passive yield generation by taking cbETH as collateral. Users can continue earning staking rewards while accessing liquidity for large purchases, portfolio adjustments, or one-time expenses, and other crypto lending services that exchanges issue solely to institutions.

Coinbase launched crypto staking services in New York late last year after receiving approval from the state’s Department of Financial Services. The platform’s staking is now available in 46 US states, excluding California, New Jersey, Maryland, and Wisconsin, which have limited or blocked retail crypto staking programs.

“Thanks to Governor Hochul’s leadership in embracing progress and providing clarity, this milestone marks a meaningful step forward in ensuring residents of the Empire State have access to the same economic opportunities already open to most other Americans,” the company said in a statement.

Coinbase-led regulatory friction threatens the US Clarity bill’s passing

As reported by Cryptopolitan last week, Coinbase CEO Brian Armstrong withdrew his support for a draft version of the Clarity Act, a crypto market structure bill. The industry is now divided, with players like Andreessen Horowitz backing the bill even as Coinbase objects to some of its provisions.

Robinhood CEO Vlad Tenev revealed that staking is among the most requested features from his company’s users, and urged the four states to consider opening their borders to the DeFi strategy. Tenev wrote on X last week that the US needs legislation that protects consumers while enabling innovation to move forward. 

“We support Congress’s efforts to pass the market structure bill. There is still work to be done, but we see a path and are here to help,” he said in a post on X.

The Senate Banking Committee delayed a vote on the bill after Armstrong announced Coinbase’s withdrawal of support in a post on X. Stablecoins account for nearly 20% of the company’s revenue, totaling $355 million in the third quarter of 2025, according to its shareholder letter.

Blockchain advocate Ron Hammond, a policy observer who is part of the Washington discussions, believes there is a 40% chance the market structure bill will be passed. “The question is, how far can they bend this bill before it breaks?” he asked.

In an interview on FOX Business, Armstrong said the crypto exchange’s main issue with the Clarity Act is competitive fairness. “It just felt deeply unfair to me that one industry bank would come in and get to do regulatory capture to ban their competition. They should have to compete on a level playing field, and I genuinely believe that.”

If you’re reading this, you’re already ahead. Stay there with our newsletter.

Source: https://www.cryptopolitan.com/coinbase-users-borrow-1-million-staked-ether/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26